Literature DB >> 28635316

Complications Following Collagenase Treatment for Dupuytren Contracture.

Jennifer Wozniczka1, Clifford Canepa2, Adam Mirarchi1, Joel S Solomon1.   

Abstract

BACKGROUND: Collagenase Clostridium histolyticum (CCH) injection and manipulation is a relatively new method for treating Dupuytren contracture that is growing in popularity. Although side effects such as swelling and ecchymosis are common, they are typically mild and self-limited. Major complications are rare but have included flexor tendon rupture and complex regional pain syndrome.
METHODS: This study describes a case report of 2 patients seen at our institution.
RESULTS: Here, we report 2 patients seen at our institution each with different, yet serious complications after CCH injection and manipulation. One patient had extensive skin loss and chose amputation over reconstruction. The other patient had loss of perfusion and required finger amputation.
CONCLUSIONS: Although it is unclear how directly the administration of CCH is connected to the observed complications, physicians should recognize the potential for serious rare complications in any treatment of Dupuytren contracture.

Entities:  

Keywords:  Dupuytren; Xiaflex; amputation; collagenase; epinephrine

Mesh:

Substances:

Year:  2017        PMID: 28635316      PMCID: PMC5684954          DOI: 10.1177/1558944717711461

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  9 in total

Review 1.  A critical look at the evidence for and against elective epinephrine use in the finger.

Authors:  Christopher J Thomson; Donald H Lalonde; Keith A Denkler; Anton J Feicht
Journal:  Plast Reconstr Surg       Date:  2007-01       Impact factor: 4.730

2.  Vascular complication after collagenase injection and manipulation for Dupuytren's contracture.

Authors:  J D Spiers; A Ullah; J J Dias
Journal:  J Hand Surg Eur Vol       Date:  2013-12-20

3.  Collagenase in the treatment of Dupuytren's disease: an in vitro study.

Authors:  K D Starkweather; S Lattuga; L C Hurst; M A Badalamente; F Guilak; S P Sampson; A Dowd; D Wisch
Journal:  J Hand Surg Am       Date:  1996-05       Impact factor: 2.230

4.  Microvascular response to locally injected collagenase. An experimental investigation in hamsters and rabbits.

Authors:  B Rydevik; T Ehira; L Linder; K Olmarker; M Romanus; P I Brånemark
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  1989

5.  Collagen-binding domain of a Clostridium histolyticum collagenase exhibits a broad substrate spectrum both in vitro and in vivo.

Authors:  T Toyoshima; O Matsushita; J Minami; N Nishi; A Okabe; T Itano
Journal:  Connect Tissue Res       Date:  2001       Impact factor: 3.417

6.  Dupuytren's fasciectomies in 60 consecutive digits using lidocaine with epinephrine and no tourniquet.

Authors:  Keith Denkler
Journal:  Plast Reconstr Surg       Date:  2005-03       Impact factor: 4.730

7.  Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.

Authors:  Clayton A Peimer; Philip Blazar; Stephen Coleman; F Thomas D Kaplan; Ted Smith; Tommy Lindau
Journal:  J Hand Surg Am       Date:  2015-06-18       Impact factor: 2.230

8.  Efficacy and tolerability of Day 2 manipulation and local anaesthesia after collagenase injection in patients with Dupuytren's contracture.

Authors:  C J Manning; R Delaney; M J Hayton
Journal:  J Hand Surg Eur Vol       Date:  2013-05-29

9.  Nonsurgical treatment of Dupuytren's contracture: 1-year US post-marketing safety data for collagenase clostridium histolyticum.

Authors:  C A Peimer; C A McGoldrick; G J Fiore
Journal:  Hand (N Y)       Date:  2012-06
  9 in total
  3 in total

Review 1.  Current role of the collagenase Clostridium histolyticum in Dupuytren's disease treatment.

Authors:  Rafael Sanjuan-Cervero
Journal:  Ir J Med Sci       Date:  2019-11-11       Impact factor: 1.568

2.  Targeting Cell Contractile Forces: A Novel Minimally Invasive Treatment Strategy for Fibrosis.

Authors:  Keerthi Atluri; Sathivel Chinnathambi; Alyssa Mendenhall; James A Martin; Edward A Sander; Aliasger K Salem
Journal:  Ann Biomed Eng       Date:  2020-03-31       Impact factor: 3.934

Review 3.  Treatment Options for Dupuytren's Disease: Tips and Tricks.

Authors:  Keith A Denkler; Keon Min Park; Osaid Alser
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.